TMPRSS2 and prostate carcinoma: The over-expression of ERG is highly attributed to the TMPRSS2: ERG fusion, a recurrent chromosomal rearrangement that represents the most common molecular alteration of prostate cancer, approximately occurring in one-half of the cases [2,5].